Stockscreener 앱 받기
4.32
3.60%
0.15
시장 영업 전:
4.32
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
OraSure receives FDA clearance for home urine collection kit for STIs - Lehigh Valley Business
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? - Yahoo Finance
FDA Clears Home Urine Collection Kit for STI Testing - Conexiant
OraSure Wins FDA Clearance for At-Home STI Collection - TipRanks
OraSure secures FDA clearance for product seen as key to future growth - WFMZ.com
OraSure stock jumps on FDA clearance for at-home STI kit - Investing.com
OraSure stock jumps on FDA clearance for at-home STI kit By Investing.com - Investing.com South Africa
OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit - Stock Titan
OraSure gets FDA nod for at-home STI urine collection kit By Investing.com - Investing.com Australia
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com India
OraSure receives FDA clearance for at-home STI urine collection kit - StreetInsider
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections - The Manila Times
FDA clears at-home urine kit that lets labs test for 4 STIs by mail - Stock Titan
OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support LevelOvernight Profile - newsline.com
Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now? - Yahoo Finance
OraSure Technologies (OSUR) director receives 46,106-share restricted stock grant - Stock Titan
OraSure (OSUR) director Nancy Gagliano receives 46,106-share stock award - Stock Titan
OraSure Technologies (OSUR) director receives 46,106-share stock grant - Stock Titan
OraSure (OSUR) director John P. Kenny granted 46,106 restricted shares - Stock Titan
Director at OraSure (NASDAQ: OSUR) receives 46,106 restricted shares - Stock Titan
Earnings call transcript: OraSure Technologies Q1 2026 misses earnings and revenue forecasts - Investing.com UK
OraSure Technologies Investors Approve Expanded Stock Plan, Governance Changes - The Globe and Mail
OraSure Technologies (NASDAQ: OSUR) OKs more equity awards and board declassification - Stock Titan
OraSure Technologies Hits New 52-Week High of $4.33, Marking Significant Growth - Markets Mojo
OSUR Q1 2026 Earnings: EPS Miss by 69% Signals Operational HeadwindsFree Cash Flow Trends - newsline.com
OraSure Technologies, Inc.Common Stock (NQ: OSUR - FinancialContent
OraSure Technologies (OSUR) Gains 6%: Testing Resistance as Momentum BuildsEase of Movement - The Legal Advocate
OraSure Technologies Hits New 52-Week High at $4.00 - Markets Mojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
OraSure Technologies Hits New 52-Week High at $4.12 - MarketsMojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance LevelNHNL Divergence - The Legal Advocate
OraSure Technologies (OSUR) price target increased by 25.00% to 5.10 - MSN
Insiders Buying OraSure Technologies Might Wish They Invested More, Stock Gains 28% - Moomoo
OraSure Technologies (OSUR) Surges 9%: Key Levels to Watch After Strong MoveBearish Pattern Stocks - The Legal Advocate
OraSure Technologies Inc. (OSUR) Q1 2026 Earnings: Wider-than-Expected Loss Raises Concerns Despite Stock SurgeInvestor Earnings Call - The Legal Advocate
OraSure Technologies (OSUR) Surges 7% as Shares Approach Resistance at $3.45Institutional Volume - newsline.com
Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
OraSure Technologies Independent Director Acquires 195% More Stock - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Insider Buying: Steven Boyd Acquires 75,000 Shares of OraSure Te - GuruFocus
OraSure director Steven Boyd purchases $224,750 in stock By Investing.com - Investing.com India
OraSure director Steven Boyd purchases $224,750 in stock - Investing.com
[Form 3] ORASURE TECHNOLOGIES INC Initial Statement of Beneficial Ownership - Stock Titan
Director at OraSure (NASDAQ: OSUR) awarded 33,661 restricted shares - Stock Titan
1.68%
0.71%
자본화:
|
볼륨(24시간):